Evolent Depreciation And Amortization from 2010 to 2024
| EVH Stock | USD 27.27 0.47 1.69% |
Depreciation And Amortization | First Reported 2013-12-31 | Previous Quarter 32.4 M | Current Value 29.6 M | Quarterly Volatility 12.3 M |
Check Evolent Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Evolent main balance sheet or income statement drivers, such as Depreciation And Amortization of 129.6 M, Total Revenue of 2.1 B or Gross Profit of 483.5 M, as well as many exotic indicators such as Price To Sales Ratio of 1.78, Dividend Yield of 0.0072 or PTB Ratio of 3.61. Evolent financial statements analysis is a perfect complement when working with Evolent Health Valuation or Volatility modules.
Evolent | Depreciation And Amortization |
Latest Evolent Health's Depreciation And Amortization Growth Pattern
Below is the plot of the Depreciation And Amortization of Evolent Health over the last few years. It is the systematic reduction in the recorded value of an intangible asset. This includes the allocation of the cost of tangible assets to periods in which the assets are used, representing the expense related to the wear and tear, deterioration, or obsolescence of physical assets and intangible assets over their useful lives. Evolent Health's Depreciation And Amortization historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Evolent Health's overall financial position and show how it may be relating to other accounts over time.
| Depreciation And Amortization | 10 Years Trend |
|
Depreciation And Amortization |
| Timeline |
Evolent Depreciation And Amortization Regression Statistics
| Arithmetic Mean | 40,442,650 | |
| Geometric Mean | 9,544,626 | |
| Coefficient Of Variation | 106.22 | |
| Mean Deviation | 34,408,960 | |
| Median | 32,368,000 | |
| Standard Deviation | 42,959,506 | |
| Sample Variance | 1845.5T | |
| Range | 129.5M | |
| R-Value | 0.93 | |
| Mean Square Error | 266.9T | |
| R-Squared | 0.87 | |
| Slope | 8,937,862 | |
| Total Sum of Squares | 25837.3T |
Evolent Depreciation And Amortization History
About Evolent Health Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Evolent Health income statement, its balance sheet, and the statement of cash flows. Evolent Health investors use historical funamental indicators, such as Evolent Health's Depreciation And Amortization, to determine how well the company is positioned to perform in the future. Although Evolent Health investors may use each financial statement separately, they are all related. The changes in Evolent Health's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Evolent Health's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Evolent Health Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Evolent Health. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Depreciation And Amortization | 123.4 M | 129.6 M |
Pair Trading with Evolent Health
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Evolent Health position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Evolent Health will appreciate offsetting losses from the drop in the long position's value.Moving against Evolent Stock
| 0.75 | DXR | Daxor | PairCorr |
The ability to find closely correlated positions to Evolent Health could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Evolent Health when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Evolent Health - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Evolent Health to buy it.
The correlation of Evolent Health is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Evolent Health moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Evolent Health moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Evolent Health can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of Evolent Health Correlation against competitors. For more detail on how to invest in Evolent Stock please use our How to Invest in Evolent Health guide.You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Complementary Tools for Evolent Stock analysis
When running Evolent Health's price analysis, check to measure Evolent Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Evolent Health is operating at the current time. Most of Evolent Health's value examination focuses on studying past and present price action to predict the probability of Evolent Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Evolent Health's price. Additionally, you may evaluate how the addition of Evolent Health to your portfolios can decrease your overall portfolio volatility.
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Stocks Directory Find actively traded stocks across global markets | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |
Is Evolent Health's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Evolent Health. If investors know Evolent will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Evolent Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.28) | Revenue Per Share 17.653 | Quarterly Revenue Growth 0.454 | Return On Assets 0.0086 | Return On Equity (0.11) |
The market value of Evolent Health is measured differently than its book value, which is the value of Evolent that is recorded on the company's balance sheet. Investors also form their own opinion of Evolent Health's value that differs from its market value or its book value, called intrinsic value, which is Evolent Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Evolent Health's market value can be influenced by many factors that don't directly affect Evolent Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Evolent Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Evolent Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Evolent Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.